The Business Research Company’s Molecular Diagnostics Devices And Equipment Market Opportunities And Strategies – Global Forecast To 2030
LONDON, GREATER LONDON, UK, June 28, 2021 /EINPresswire.com/ — Diagnostic start up DIVOC Health has recently gotten an approval for a novel PCR assay to detect COVID-19 more efficiently. The polymerase chain reaction testing kit is in a ready-to-go bead format, which allows it to endure higher temperatures. This is helpful because it makes it suitable for more tropical countries, where the need for cold-storage is a hindrance.
COVID-19 rapid test kits are usually available as RT PCR test kits, rapid antigen test kits or rapid antibody test kits and are manufactured by the entities that manufacture in-vitro rapid diagnostic tests in the medical equipment industry.
Increasing demand for molecular diagnostics for COVID-19 has been a major driver of the molecular diagnostic devices and equipment market. There has been an increase in the adoption of next generation sequencing technology in the diagnostics of infections owing to its high efficiency and accuracy. In June 2020, FDA issued an emergency use authorization to Ilumina Inc., for Illumina COVIDSeq Test, the first COVID-19 diagnostic test utilizing next generation sequence technology. The advantage of using a next generation sequencing test is that it can generate information about the genomic sequence of the virus present in a sample along with detecting the presence of the virus in the sample. This genomic information can be used for research purposes too, thus supporting the growth of the market.
As per data on the Global Market Model, the global molecular diagnostics devices and equipment market is expected to decline from $18.07 billion in 2020 to $13.57 billion in 2021 at a compound annual growth rate (CAGR) of -24.9%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $19.01 billion in 2025 at a CAGR of 8.8%.
The top opportunities in the molecular diagnostics devices and equipment market segmented by product will arise in the reagents and consumables segment, which will gain $610.6 million of global annual sales by 2025. The top opportunities in the market segmented by end-user will arise in the diagnostic laboratories segment, which will gain $530.6 million of global annual sales by 2025, segmented by technology will arise in the DNA (deoxyribonucleic acid) sequencing segment, which will gain $304.7 million of global annual sales by 2025, by application will arise in the genetic testing segment, which will gain $345.8 million of global annual sales by 2025. The molecular diagnostics devices and equipment market size will gain the most in the Japan at $171.3 million.
About The Global Market Model
The Global Market Model is the world’s most comprehensive database of integrated market information available. The ten-year forecasts in the Global Market Model are updated in real time to reflect the latest market realities, which is a huge advantage over static, report-based platforms.
Here Is A List Of Related Reports From The Business Research Company
Microbiology Diagnostic Devices And Equipment Market – By Type (Laboratory Instruments, Microbiology Analyzers, Reagents And Consumables) By End-User (Hospitals, Diagnostic Laboratories, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2021: COVID-19 Growth And Change to 2030
Interested To Know More About The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. The Global Market Model is The Business Research Company’s flagship product.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info